Username Password
S&P 500: 2,117.69
Change: +0.23%

MEDIVATION INC. (MDVN)

Overview
Price 131.01
Price Change Today -$1.50 (-1.13%)
P&P rating Rating: 2
Open Price $132.03
Previous Close $132.51
Daily Range $130.24 - $132.51
52-Week Range $55.25 - $141.58
Volume 665
chart
Top Buy Analysis
BUY: MDVN Rating: 2
Company: MEDIVATION INC.
Points: 251.53
Start Price: $31.37
Start Date: 09/03/2008 8:31 PM
beachdude
beachdude
P&P Score: 93.77
Recs:
Impressive management with great business strategy. good pipeline of new products

Comments: 0 | Comment

Top Sell Analysis
SELL: MDVN Rating: 2
Company: MEDIVATION INC.
Points: -15.35
Start Price: $113.20
Start Date: 02/23/2015 10:31 AM
JoeJustJoe
JoeJustJoe
P&P Score: 1.08
Recs:
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

13 Buy
2 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.99 02/28/14 Market Sells off in the afternoon = High flyers taking a breather 6 02/28/14
zantriocom
0.00 03/16/10 Zantrio.com Free Daily Stock Picks 3-16-2010 0
Neurodoc
99.18 02/03/10 M&M boys up on healthy volume today 4 02/11/10
Zacks_Analysts
0.00 02/15/13 Eylea Drives Regeneron - Analyst Blog 0
Zacks_Analysts
0.00 02/15/13 Eylea Drives Regeneron - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Priority Review for Bayer's Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Priority Review for Bayer's Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Alexion 4Q Tops on Both Lines - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Alexion 4Q Tops on Both Lines - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Priority FDA Review for Celgene Drug - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  14  >>
Commentary
SELL: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $113.20
Points: -15.35
Created: 02/23/2015
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Recs:
 
SELL: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $113.20
Points: -15.95
Created: 02/23/2015
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Recs:
 
SELL: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $113.20
Points: -15.81
Created: 02/23/2015
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Recs:
 
SELL: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $113.20
Points: -15.35
Created: 02/23/2015
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Recs:
 
SELL: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $113.20
Points: -15.95
Created: 02/23/2015
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Recs:
 
SELL: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $113.20
Points: -15.81
Created: 02/23/2015
Needed 112.82+ this time up ann 112.86 is a CT. Trendlow at 48.76.

Comments: 2 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +490.87
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +491.92
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +491.67
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +490.87
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
clangmead 99.93 BUY Six Months to a Year 04/13/2015 $132.92 $131.01
(-1.13%)
-1.44% +1.21% -2.64 view
clangmead 99.93 BUY Six Months to a Year 04/13/2015 $132.92 $131.01
(-1.13%)
-1.44% +0.60% -2.04 view
clangmead 99.93 BUY Six Months to a Year 04/13/2015 $132.92 $131.01
(-1.13%)
-1.44% +0.74% -2.18 view
clangmead 99.93 BUY Six Months to a Year 04/13/2015 $132.92 $131.01
(-1.13%)
-1.44% +1.21% -2.64 view
clangmead 99.93 BUY Six Months to a Year 04/13/2015 $132.92 $131.01
(-1.13%)
-1.44% +0.60% -2.04 view
clangmead 99.93 BUY Six Months to a Year 04/13/2015 $132.92 $131.01
(-1.13%)
-1.44% +0.74% -2.18 view
JoeJustJoe 1.08 SELL Six Months to a Year 02/23/2015 $113.20 $131.01
(-1.13%)
+15.73% +0.38% -15.35 view
JoeJustJoe 1.08 SELL Six Months to a Year 02/23/2015 $113.20 $131.01
(-1.13%)
+15.73% -0.22% -15.95 view
JoeJustJoe 1.08 SELL Six Months to a Year 02/23/2015 $113.20 $131.01
(-1.13%)
+15.73% -0.08% -15.81 view
JoeJustJoe 1.08 SELL Six Months to a Year 02/23/2015 $113.20 $131.01
(-1.13%)
+15.73% +0.38% -15.35 view
Pages: [ 1 ]  2  >>
Sponsored Links